輸入代號或公司名稱後按 Enter
4123

晟德

-0.10 (-0.33%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
30.251,051成交張數22.74本益比1.33股價淨值比7.42%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度資產總額(億)母公司權益(億)負債比率流動比率每股淨值ROE(近四季)ROA(近四季)營業現金流(億)自由現金流(億)
2026Q224017228.4%1.8522.336.0%4.3%0.2-0.1
2026Q137728324.9%0.9337.2345.7%33.9%1.21.0
2025Q434626523.5%0.4534.7941.9%31.0%0.90.3
2025Q325819623.9%0.5127.099.1%6.9%0.50.1
2025Q223716829.0%0.4723.17-3.8%-2.6%-1.3-2.2
2025Q125618627.1%0.8525.69-0.1%-0.1%0.20.0
2024Q425518129.3%0.8224.90-5.8%-4.2%1.81.1
2024Q326019325.9%0.9626.60-2.2%-1.6%1.00.5
2024Q227018830.6%2.2126.13-8.8%-6.1%0.1-0.1
2024Q127119327.3%4.7927.85-12.8%-9.2%1.20.9
2023Q427019825.1%2.7828.57-5.1%-3.8%0.2-0.6
2023Q327018629.5%1.6828.19-4.8%-3.4%0.60.1
2023Q227619328.4%1.0132.47-5.3%-3.8%-10.8-11.0
2023Q127720225.3%0.6433.99-1.3%-0.9%0.50.3
2022Q425219323.6%0.7332.370.5%0.4%1.31.2
2022Q326019226.3%0.8432.29-3.2%-2.1%-0.9-1.0
2022Q226219223.9%1.3837.97-1.7%-1.1%-1.6-1.6
2022Q129320624.1%4.0240.775.2%3.5%-0.6-0.6
2021Q430418930.7%4.0637.509.8%6.2%-0.9-0.9
2021Q332419729.1%2.5638.9421.5%13.6%-0.3-0.3
2021Q234421226.0%3.6346.1131.7%20.0%-2.6-2.6
2021Q132020125.2%0.2843.6633.8%20.9%0.20.2
2020Q427918025.9%0.5239.1524.2%14.9%0.10.0
2020Q324816524.2%0.8736.0015.8%9.7%-0.3-0.4
2020Q222114526.8%0.2833.9510.1%5.7%-2.4-2.5
2020Q122413627.0%0.5332.431.0%0.6%-0.1-0.5
2019Q422913332.4%0.3931.73-2.2%-1.3%-0.1-1.3
2019Q322212235.2%0.6029.6336.3%11.9%0.40.9
2019Q225412336.4%1.3934.7255.8%15.9%-2.9-4.1
2019Q121012828.0%0.9236.1653.5%17.4%-0.2-4.3
2018Q420413124.1%1.5437.1561.2%20.7%-2.9-3.8
2018Q34138656.5%1.5524.4631.8%6.2%4.31.1
2018Q24176760.7%1.4020.5113.1%2.3%6.31.8
2018Q14147457.0%1.0123.2210.2%2.0%-1.5-10.8
2017Q43836856.0%1.0321.203.7%0.7%2.6-4.8
2017Q33616654.4%1.0920.53-0.9%-0.2%1.6-5.6
2017Q23416653.0%1.2022.761.3%0.3%7.81.3
2017Q13086649.2%1.2422.600.9%0.2%8.21.6
2016Q43046847.9%1.3023.2810.75.8
2016Q33077446.4%1.4425.23-0.6-4.5